Compared with the control group, the levels of cleaved caspase-9, cleaved caspase-3 and Bax protein in the ischemic group were notably increased (p < 0.01), and it was decreased after MTC treatment. The gene discussed is CASP3; the disease is medullary thyroid gland carcinoma.